Jason Jones, MD
Ophthalmology · Sioux City, IANPI 1922002872
Payments from drug & device makers
Across 413 payments — averaging $4579.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$1.5M
- Glaukos Corporation$325K
- Alcon Research LLC$60K
- Ivantis, Inc$20K
- Carl Zeiss Meditec USA, Inc.$6K
- AbbVie$449
- plus $2K from 16 others
Across 1 payment — averaging $4549.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glaukos Corporation$5K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 118 | $1,478,177 |
| Glaukos Corporation | 142 | $324,972 |
| Alcon Research LLC | 54 | $59,532 |
| Ivantis, Inc | 18 | $19,984 |
| Carl Zeiss Meditec USA, Inc. | 12 | $5,835 |
| AbbVie(2 entities) | 16 | $449 |
| Rxsight Inc | 4 | $442 |
| Alcon | 9 | $412 |
| The Cameron-ehlen Group, Inc. | 3 | $294 |
| Amgen(2 entities) | 13 | $238 |
| Biotissue Holdings Inc. | 6 | $234 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $218 |
| Lensar, Inc. | 2 | $201 |
| Beaver-visitec International, Inc. | 1 | $109 |
| Apellis Pharmaceuticals, Inc. | 1 | $92 |
| Carl Zeiss Meditec, Inc. | 1 | $65 |
| Astellas Pharma US Inc | 1 | $24 |
| Stemline Therapeutics Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $22 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Sight Sciences, Inc. | 1 | $16 |
| Dompe US, Inc. | 1 | $13 |
How this compares
$1,891,373 in reported general payments places this provider in the 95th percentile of 172 ophthalmology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Sioux City
- Michael WadzinskiSioux City$4K
- James FolkIowa City$5.1M
- Jared NielsenWest Des Moines$3.1M
- Michael AbramoffIowa City$1.9M
- Stephen RussellIowa City$1.8M
- Matthew RauenWest Des Moines$756K
- Edward HuHiawatha$581K
- Alina DumitrescuIowa City$264K
- Kyle AllimanWest Des Moines$100K
- Christy BensonDes Moines$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.